The majority COVID-19 infections caused by the highly contagious omicron variant were reinfections, according to a new study from the United Kingdom.
were reinfections, according to a study from the United Kingdom released Wednesday. Participants in the study who tested positive reported to researchers from Imperial College London whether they had tested positive in the past, and more than two-thirds said they had.
The study, which analyzed 100,000 PCR tests taken in January, flies in the face of previous ideas about immunity bestowed by a prior COVID-19 infection. Scientists estimate the risk of reinfection by omicron is 5.4 times higher than with COVID-19’s once-dominant variant, delta. “We observed unprecedented levels of infection with SARS-CoV-2 in England in January 2022 and almost complete replacement of delta by omicron,” the study’s authors wrote.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19 news: Strain on health services led to extra non-covid deathsToday’s covid-19 news: · 4000 excess non-covid 19 deaths occurred in England during first year of pandemic · Acute phase of pandemic could end in 2022 with improved vaccination rates, says WHO · Israel recommends fourth vaccine dose for all adults
Read more »
Elton John Postpones Two Dallas Shows After Catching Covid-19“Fortunately, I’m fully vaccinated and boosted and my symptoms are mild so I’m fully expecting to make the Arkansas shows this weekend”
Read more »
Red wine could reduce chances of COVID-19 infection, U.K. study suggestsA recent study out of the U.K. suggested consuming up to two glasses of red wine a week could lower a person’s chance of getting infected with COVID-19.
Read more »
COVID-19 vaccines could temporarily impact length of menstrual cycles, study saysThe women who received a vaccine saw an increase in cycle length of nearly one day for each dose, according to the study.
Read more »
Pfizer, BioNTech begin omicron-specific COVID-19 vaccine studyCOVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Read more »
Pfizer launches study of omicron-specific COVID-19 vaccineBoosters still protect against severe disease.
Read more »